Sensus Healthcare, Inc. (NASDAQ:SRTS) insider Richard Golin sold 7,334 shares of Sensus Healthcare stock in a transaction on Tuesday, September 12th. The stock was sold at an average price of $6.00, for a total value of $44,004.00. Following the sale, the insider now owns 971,509 shares of the company’s stock, valued at $5,829,054. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Richard Golin also recently made the following trade(s):

  • On Wednesday, September 6th, Richard Golin sold 8,012 shares of Sensus Healthcare stock. The stock was sold at an average price of $6.00, for a total value of $48,072.00.

Sensus Healthcare, Inc. (NASDAQ:SRTS) traded up 1.19% during mid-day trading on Thursday, hitting $5.96. The stock had a trading volume of 18,686 shares. The firm’s 50-day moving average price is $5.99 and its 200 day moving average price is $5.00. Sensus Healthcare, Inc. has a one year low of $3.61 and a one year high of $6.50. The company’s market cap is $80.39 million.

Sensus Healthcare (NASDAQ:SRTS) last released its quarterly earnings results on Thursday, August 3rd. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.08. The business had revenue of $4.97 million during the quarter, compared to analysts’ expectations of $4.50 million. Sensus Healthcare had a negative return on equity of 16.40% and a negative net margin of 13.31%. On average, equities research analysts anticipate that Sensus Healthcare, Inc. will post ($0.33) EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/09/14/sensus-healthcare-inc-srts-insider-richard-golin-sells-7334-shares.html.

Separately, Maxim Group began coverage on Sensus Healthcare in a research report on Tuesday, June 6th. They set a “buy” rating and a $6.50 target price for the company.

An institutional investor recently bought a new position in Sensus Healthcare stock. B. Riley Financial Inc. purchased a new position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 104,794 shares of the company’s stock, valued at approximately $421,000. B. Riley Financial Inc. owned 0.77% of Sensus Healthcare at the end of the most recent quarter. Hedge funds and other institutional investors own 10.46% of the company’s stock.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.

Insider Buying and Selling by Quarter for Sensus Healthcare (NASDAQ:SRTS)

Receive News & Ratings for Sensus Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.